Results 31 to 40 of about 967,275 (342)

Solid bioneedle-delivered influenza vaccines are highly thermostable and induce both humoral and cellular immune responses. [PDF]

PLoS ONE, 2014
The potential of bioneedles to deliver influenza vaccines was investigated. Four influenza vaccine formulations were screened to determine the optimal formulation for use with bioneedles.
Peter C Soema, Geert-Jan Willems, Klaas van Twillert, Gijsbert van de Wijdeven, Claire J Boog, Gideon F A Kersten, Jean-Pierre Amorij   +6 more
doaj   +1 more source

Influenza and Influenza Vaccine: A Review [PDF]

Journal of Midwifery & Women's Health, 2021
AbstractInfluenza is a highly contagious, deadly virus, killing nearly half a million people yearly worldwide. The classic symptoms of influenza are fever, fatigue, cough, and body aches. In the outpatient setting, diagnosis can be made by clinical presentation with optional confirmatory diagnostic testing.
Cynthia Nypaver, Cynthia Dehlinger, Chelsea Carter   +2 more
openaire   +2 more sources

An Overview of Influenza Viruses and Vaccines

Vaccines, 2021
Influenza remains one of the major public health concerns because it causes annual epidemics and can potentially instigate a global pandemic. Numerous countermeasures, including vaccines and antiviral treatments, are in use against seasonal influenza ...
R. Nuwarda, A. Alharbi, Veysel Kayser
semanticscholar   +1 more source

A Research and Development (R&D) roadmap for influenza vaccines: Looking toward the future.

Vaccine, 2021
Improved influenza vaccines are urgently needed to reduce the burden of seasonal influenza and to ensure a rapid and effective public-health response to future influenza pandemics.
K. Moore, J. Ostrowsky, Alison Kraigsley, Angela J Mehr, J. Bresee, M. Friede, B. Gellin, Josie Golding, Peter Hart, A. Moen, C. Weller, M. Osterholm, W. Ampofo, W. Barclay, M. Cavaleri, C. Cohen, B. Cowling, R. Cox, Ian Gust, B. Innis, G. Kang, J. Katz, F. Krammer, P. Pitisuttithum, Diane J Post, L. Rudenko, M. Siqueira, J. Weir   +27 more
semanticscholar   +1 more source

Agent-based model of the impact of higher influenza vaccine efficacy on seasonal influenza burden

Vaccine: X, 2023
Introduction: Current influenza vaccines have limited effectiveness. COVID-19 vaccines using mRNA technology have demonstrated very high efficacy, suggesting that mRNA vaccines could be more effective for influenza. Several such influenza vaccines are in
Mary G. Krauland, Richard K. Zimmerman, Katherine V. Williams, Jonathan M. Raviotta, Lee H. Harrison, John V. Williams, Mark S. Roberts   +6 more
doaj   +1 more source

Influenza Vaccines: Successes and Continuing Challenges

Journal of Infectious Diseases, 2021
Influenza vaccines have been available for over 80 years. They have contributed to significant reductions in influenza morbidity and mortality. However, there have been limitations in their effectiveness, in part due to the continuous antigenic evolution
T. Becker, Husni Elbahesh, L. Reperant, G. Rimmelzwaan, A. Osterhaus   +4 more
semanticscholar   +1 more source

Influenza vaccination

Nursing Older People, 1999
Nurses have an important part to play in dispelling myths about influenza vaccination and in actively encouraging older people to attend for vaccination. Irene Schofield discusses the issues.
A, Uma, P, Thirumalaikolundusubramanian
openaire   +5 more sources

Haemagglutination inhibition and virus microneutralisation serology assays: use of harmonised protocols and biological standards in seasonal influenza serology testing and their impact on inter-laboratory variation and assay correlation: A FLUCOP collaborative study

Frontiers in Immunology, 2023
IntroductionThe haemagglutination inhibition assay (HAI) and the virus microneutralisation assay (MN) are long-established methods for quantifying antibodies against influenza viruses. Despite their widespread use, both assays require standardisation to
Joanna Waldock, Edmond J. Remarque, Lingyi Zheng, Sammy Ho, Katja Hoschler, Britta Neumann, Hanna Sediri-Schön, Claudia M. Trombetta, Emanuele Montomoli, Serena Marchi, Giulia Lapini, Fan Zhou, Sarah L. Lartey, Rebecca J. Cox, Marzia Facchini, Maria Rita Castrucci, Damien Friel, Thierry Ollinger, Catherine Caillet, Nedzad Music, Giuseppe Palladino, Othmar G. Engelhardt, the FLUCOP consortium   +22 more
doaj   +1 more source

Engineered Nanoparticulate Vaccines to Combat Recurring and Pandemic Influenza Threats

Advanced NanoBiomed Research, 2022
Recurring seasonal flu epidemics and occasional pandemics are among the most severe threats to public health. Current seasonal influenza vaccines provide limited protection against drifted circulating strains and no protection against influenza pandemics.
Chunhong Dong, Bao-Zhong Wang
doaj   +1 more source

Public Interest in Distribution and Determinants of Influenza and Pneumonia Vaccination during the COVID-19 Pandemic: An Infodemiology and Cross-Sectional Study from China

Vaccines, 2021
Background: Following the COVID-19 pandemic, global interest in influenza vaccines and pneumonia vaccines has increased significantly. We aimed to examine public interest in and actual market circulation of influenza and pneumonia vaccines before and ...
Liubing Gong, Xu Zhang, Zhiqiang Qu, Mark R. Francis, Kaiyi Han, Cuilin Xu, Enmao Cai, Huilin Shi, Zhiyuan Hou   +8 more
doaj   +1 more source